CARLSBAD, Calif., June 24 /PRNewswire/ -- SkinMedica(R), Inc., launches a new informational web site, TNSRecoveryComplex.com, centered around the top-selling product, TNS Recovery Complex(R). The site is designed to communicate with and provide consumers with a greater understanding of the science and efficacy of NouriCel-MD(R), the active ingredient in TNS Recovery Complex(R), and the growing TNS(R) Collection.
TNSRecoveryComplex.com features eight pages -- where visitors can learn more about the ingredients, products and the brand in the click of a button -- including "Our Secret" explaining where the idea of TNS Recovery Complex stemmed from; "Our Formula" describes NouriCel-MD(R); "The Benefits" of TNS(R); "The Collection" provides an overview of all six SkinMedica product offerings by category; "Find TNS" tells visitors where they can locate a physician's office or medically supervised spa; "FAQ" features the top frequently asked questions; "Contact" for further inquiries; and "Login" for medical professionals only. The site, http://www.TNSRecoveryComplex.com is currently live.
Screen Grab from the TNSRecoveryComplex.com Home Page:
SkinMedica, Inc. is an aesthetic and pharmaceutical company focused on developing, acquiring and commercializing products that improve the appearance of skin and treat dermatologic conditions and diseases.
SkinMedica is a privately held specialty pharmaceutical company marketing both prescription and cosmeceutical dermatology products. SkinMedica's Desonate(R) (desonide) Gel 0.05% is indicated for the treatment of mild-to-moderate atopic dermatitis; EpiQuin(R) Micro (4% hydroquinone) cream is indicated for melasma and postinflammatory hyperpigmentation; VANIQA(R) (eflornithine hydrochloride) Cream, 13.9%, is the only FDA-approved prescription product for the treatment of unwanted facial hair in women; and NeoBenz(R) Micro Cream and NeoBenz(R) Micro SD (single dose) are the only benzoyl peroxide prescription products that contain a patented gradual-release formulation of benzoyl peroxide to treat acne. The company's full line of cosmeceutical products, which is sold through physicians, includes TNS Recovery Complex(R) with NouriCel-MD(R) to help improve the health and appearance of aging skin. SkinMedica is based in Carlsbad, California. For more information, visit http://www.skinmedica.com.
SkinMedica cautions you that statements included in this press release that are not a description of historical facts may be forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by SkinMedica that any of its plans will be achieved. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in SkinMedica's business due to a number of factors, including: (i) we and our products face significant competition; (ii) if we do not successfully manage any growth we experience, we may experience increased expenses without corresponding revenue increases; (iii) we are dependent on third parties for supply of all the products we offer; (iv) unexpected adverse side effects or inadequate therapeutic efficacy of our products could delay or prevent product development or commercialization, or could result in recalls or product liability claims; and (v) we may not be able to identify appropriate acquisition, licensing, or co-promotion candidates in the future or to take advantage of the opportunities we identify. All forward-looking statements are qualified in their entirety by this cautionary statement and SkinMedica undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof.
SkinMedica(R), Desonate(R), EpiQuin(R) Micro, NeoBenz(R) Micro,
NouriCel-MD(R), TNS Recovery Complex(R), and VANIQA(R) are registered
trademarks of SkinMedica, Inc.
|SOURCE SkinMedica, Inc.|
Copyright©2008 PR Newswire.
All rights reserved